Markers of inflammation in the breath in paediatric inflammatory bowel disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 59, Issue 4, 2014, Pages 505-510

  Huang, Yixi ^a   Lemberg, Daniel A ^b   Day, Andrew S ^c   Dixon, Barbara ^d   LeaC H , Steven ^b   Bujanover, Yoram ^b   Jaffe, Adam ^d   Thomas, Paul S ^a  

^a Edmond and Lily Safra Children s Hospital Sheba Medical Center   (Israel)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

8 Isoprostane; Exhaled breath; Mucin; PH; Trefoil factors

Indexed keywords

8 ISOPROSTANE; INTESTINAL TREFOIL FACTOR; MUCIN; NITRIC OXIDE; TREFOIL FACTOR 2; UNCLASSIFIED DRUG; 8-EPI-PROSTAGLANDIN F2ALPHA; AUTACOID; BIOLOGICAL MARKER; ISOPROSTANE DERIVATIVE; PEPTIDE; PROSTAGLANDIN F2 ALPHA; TREFOIL FACTOR;

ARTICLE; ASTHMA; BREATH ANALYSIS; CHILD; CONTROLLED STUDY; CROHN DISEASE; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE MARKER; EXHALED BREATH CONDENSATE; EXPIRED AIR; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PH; PILOT STUDY; PRICK TEST; SPIROMETRY; ADOLESCENT; ANALOGS AND DERIVATIVES; COMPARATIVE STUDY; EXHALATION; INFLAMMATION; LUNG; METABOLISM; REFERENCE VALUE;

LOTUS;

ADOLESCENT; ASTHMA; BIOLOGICAL MARKERS; BREATH TESTS; CHILD; CROHN DISEASE; CROSS-SECTIONAL STUDIES; DINOPROST; EXHALATION; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; INFLAMMATION; INFLAMMATION MEDIATORS; ISOPROSTANES; LUNG; MALE; MUCINS; NITRIC OXIDE; PEPTIDES; PILOT PROJECTS; REFERENCE VALUES;

EID: 84917695829     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000000450     Document Type: Article

References (35)

1. Mutlu GM, Garey KW, Robbins RA, et al. Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med 2001; 164: 731-7.
2. Montuschi P, Barnes PJ. Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol Sci 2002; 23: 232-7.
3. Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and pathophysiology of inflammatory bowel disease. Clin Microbiol Rev 2002; 15: 79-94.
4. Taupin D, Podolsky DK. Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol 2003; 4: 721-32.
5. Iskandar HN, Ciorba MA. Biomarkers in inflammatory bowel disease: current practices and recent advances. Transl Res 2012; 159: 313-25.
6. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a Paediatric Crohn's Disease Activity Index. J Pediatr Gastroenterol Nutr 1991; 12: 439.
7. Hyams J, Walters TD, Crandall W, et al. Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extension. Curr Med Res Opin 2011; 27: 651-62.
8. Thomas P, Lowe A, Samarasinghe P, et al. Exhaled breath condensate in pediatric asthma: promising new advance or pouring cold water on a lot of hot air? A systematic review. Pediatr Pulmonol 2013; 48: 419-42.
9. Profita M, La Grutta S, Carpagnano E, et al. Noninvasive methods for the detection of upper and lower airway inflammation in atopic children. J Allergy Clin Immunol 2006; 118: 1068-74.
10. Carraro S, Folesani G, Corradi M, et al. Acid-base equilibrium in exhaled breath condensate of allergic asthmatic children. Allergy 2005; 60: 476-81.
11. Brunetti L, Francavilla R, Tesse R, et al. Exhaled breath condensate pH measurement in children with asthma allergic rhinitis and atopic dermatitis. Pediatr Allergy Immunol 2006; 17: 422-7.
12. Lin J-L, Thomas PS. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease. COPDV 7 2010: 291-306.
13. Montuschi P, Barnes PJ, Ciabattoni G. Measurement of 8-isoprostane in exhaled breath condensate. Methods Mol Biol 2010; 594: 73-84.
14. Lucidi V, Ciabattoni G, Bella S, et al. Exhaled 8-isoprostane and prostaglandin E2 in patients with stable and unstable cystic fibrosis. Free Radic Biol Med 2008; 45: 913-9.
15. Barreto M, Villa MP, Olita C, et al. 8-Isoprostane in exhaled breath condensate and exercise-induced bronchoconstriction in asthmatic children and adolescents. Chest 2009; 135: 66-73.
16. Shahid SK, Kharitonov SA, Wilson NM, et al. Exhaled 8-isoprostane in childhood asthma. Respir Res 2005; 6: 79.
17. Mondino C, Ciabattoni G, Koch P, et al. Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children. J Allergy Clin Immunol 2004; 114: 761-7.
18. Zanconato S, Carraro S, Corradi M, et al. Leukotrienes and 8-isoprostane in exhaled breath condensate of children with stable and unstable asthma. J Allergy Clin Immunol 2004; 113: 257-63.
19. Profita M, Montuschi P, Bonanno A, et al. Novel perspectives in the detection of oral and nasal oxidative stress and inflammation in pediatric united airway diseases. Int J Immunopathol Pharmacol 2010; 23: 1211-9.
20. Kjellev S. The trefoil factor family-small peptides with multiple functionalities. Cell Mol Life Sci 2009; 66: 1350-69.
21. Barrett NA, Austen KF. Innate cells and T helper 2 cell immunity in airway inflammation. Immunity 2009; 31: 425-37.
22. Buhner S, Buning C, Genschel J, et al. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation? Gut 2006; 55: 342-7.
23. Irvine EJ, Marshall JK. Increased intestinal permeability precedes the onset of Crohn's disease in a subject with familial risk. Gastroenterology 2000; 119: 1740-4.
24. Xavier R, Podolsky D. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-34.
25. Smith AD, Cowan JO, Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005; 352: 2163-73.
26. Montuschi P, Mondino C, Koch P, et al. Effects of montelukast treatment and withdrawal on fractional exhaled nitric oxide and lung function in children with asthma. Chest 2007; 132: 1876-81.
27. Kharitonov S, Yates D, Robbins R, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133-5.
28. van Rensen ELJ, Straathof K, Veselic-Charvat MA, et al. Effect of inhaled steroids on airway hyperresponsiveness sputum eosinophils and exhaled nitric oxide levels in patients with asthma. Thorax 1999; 54: 403-8.
29. Kharitonov S, Yates D, Chung K, et al. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 1996; 9: 196-201.
30. Cross RK, Wilson KT. Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis 2003; 9: 179-89.
31. Montuschi P, Paris D, Melck D, et al. NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis. Thorax 2012; 67: 222-8.
32. Motta A, Paris D, Melck D, et al. Nuclear magnetic resonance-based metabolomics of exhaled breath condensate: methodological aspects. Eur Respir J 2012; 39: 498-500.
33. Wheelock CE, Goss VM, Balgoma D, et al. Application of 'omics technologies to biomarker discovery in inflammatory lung diseases. Eur Respir J 2013; 42: 802-25.
34. Bofan M, Mores N, Baron M, et al. Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD. J Breath Res 2013; 7: 017103.
35. Montuschi P, Mores N, Trové A, et al. The electronic nose in respiratory medicine. Respiration 2013; 85: 72-84.